NCT03959176View on ClinicalTrials.gov

The Effect of Brimonidine

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 20, 2019

Primary Completion Date

July 20, 2019

Study Completion Date

July 20, 2019

Conditions
Intraocular Pressure
Interventions
DRUG

Brimonidine

2 drops administered once in the left eye in both study arms

DRUG

Tropicamide

1 drop administered at two different times points in both eyes in both study arms

DRUG

Phenylephrine Ophthalmic Product

1 drop administered at two different time points in both eyes in both study arms

Trial Locations (1)

27157

Wake Forest Baptist Medical Center, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT03959176 - The Effect of Brimonidine | Biotech Hunter | Biotech Hunter